Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Go back to Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Aperture Health, Inc. (NASDAQ: APRE) Delayed: 0.63 --0 (-0%)
Previous Close $0.63    52 Week High $0.08 
Open $0.63    52 Week Low $0.00 
Day High $0.63    P/E N/A 
Day Low $0.63    EPS $0.00 
Volume